Access to Care: Safety of Medication Abortion - Frankly Speaking EP 281

Clinicians may hesitate to provide medication abortion without first performing a pelvic ultrasound or pelvic examination, but recent data may give clinicians more confidence in their decision to do so. This episode explores the evidence for the safety of telehealth-based, or no-test screening, approaches to providing medication abortion for pregnant women at less than 10 weeks’ gestation. 

Episode references and resource links: 

  • Upadhyay UD, Raymond EG, Koenig LR, et al. Outcomes and Safety of History-Based Screening for Medication Abortion: A Retrospective Multicenter Cohort Study. JAMA Intern Med. Published online March 21, 2022. doi:10.1001/jamainternmed.2022.0217
  • Upadhyay UD, Koenig LR, Meckstroth KR. Safety and Efficacy of Telehealth Medication Abortions in the US During the COVID-19 Pandemic. JAMA Network Open. 2021;4(8):e2122320. doi:10.1001/jamanetworkopen.2021.22320
  • Endler M, Lavelanet A, Cleeve A, Ganatra B, Gomperts R, Gemzell-Danielsson K. Telemedicine for medical abortion: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology. 2019;126(9):1094-1102. doi:10.1111/1471-0528.15684

Learning Objectives

  • Identify the medications used to terminate pregnancy less than 10 weeks’ gestation
  • Discuss the approaches to screening eligibility for medication abortion
  • Evaluate the risks and benefits to a history-based screening eligibility

     

Additional Information

Partner: 
Pri-Med
Course summary
Available credit: 
  • 0.25 AMA PRA Category 1 Credit™
Course opens: 
06/20/2022
Course expires: 
06/20/2024
Rating: 
0

Frank J. Domino, MD

Professor, Family Medicine and Community Health,
University of Massachusetts Medical School, Worcester, MA

Jillian Joseph, MPAS, PA-C

Assistant Professor, Department of PA Studies, Massachusetts College of Pharmacy, Boston, MA
Clinical Instructor, Department of Family Medicine & Community Health, University of Massachusetts Medical School, Worcester, MA

AMA PRA Category 1 Credits™

Accreditation Statement

Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Pri-Med Institute designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 0.25 AMA PRA Category 1 Credit™
Please login or register to take this course.

This course is offered through Pri-Med. 

To take this course you will be redirected to Pri-Med's website. You must login or create an account with Pri-Med in order to complete this activity. 

Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch